NFKB1 and diabetic kidney disease: It was observed that chronic treatment with pyrrolidine dithiocarbamate (PDTC), a NF-κB inhibitor, effectively blocked the activation of renal TLR4, NF-κB, and IL-6, without interfering with blood glucose levels in rats with STZ-induced DKD [134].